| Bioactivity | Forigerimod TFA (IPP-201101 TFA) is a CD4 T-cell modulator. Forigerimod TFA is a 21-amino-acid fragment of U1 small nuclear ribonucleoprotein 70 kDa that is phosphorylated at Ser140. Forigerimod TFA can potently inhibit autophagy. Forigerimod can be used for the research of autoimmune disorders, such as systemic lupus erythematosus (SLE) [1][2][3][4]. | ||||||
| Name | Forigerimod TFA | ||||||
| Shortening | RIHMVYSKR-{Ser-phosphono}-GKPRGYAFIEY (TFA) | ||||||
| Formula | C119H182F3N34O34PS | ||||||
| Molar Mass | 2752.96 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light, under nitrogen
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen) |
Forigerimod TFA
CAS: F: C119H182F3N34O34PS W: 2752.96
Forigerimod TFA (IPP-201101 TFA) is a CD4 T-cell modulator. Forigerimod TFA is a 21-amino-acid fragment of U1 small nucl
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.